BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34907092)

  • 1. Structure-Based Virtual Screening for Ligands of G Protein-Coupled Receptors: What Can Molecular Docking Do for You?
    Ballante F; Kooistra AJ; Kampen S; de Graaf C; Carlsson J
    Pharmacol Rev; 2021 Oct; 73(4):527-565. PubMed ID: 34907092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of virtual screening against GPCR homology models: Impact of template selection and treatment of binding site plasticity.
    Jaiteh M; Rodríguez-Espigares I; Selent J; Carlsson J
    PLoS Comput Biol; 2020 Mar; 16(3):e1007680. PubMed ID: 32168319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational Design of Drugs Targeting G-Protein-Coupled Receptors: Ligand Search and Screening.
    Luginina AP; Khnykin AN; Khorn PA; Moiseeva OV; Safronova NA; Pospelov VA; Dashevskii DE; Belousov AS; Borschevskiy VI; Mishin AV
    Biochemistry (Mosc); 2024 May; 89(5):958-972. PubMed ID: 38880655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revolutionizing GPCR-ligand predictions: DeepGPCR with experimental validation for high-precision drug discovery.
    Zhang H; Fan H; Wang J; Hou T; Saravanan KM; Xia W; Kan HW; Li J; Zhang JZH; Liang X; Chen Y
    Brief Bioinform; 2024 May; 25(4):. PubMed ID: 38864340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic insights into sodium ion-mediated ligand binding affinity and modulation of 5-HT2B GPCR activity: implications for drug discovery and development.
    Chauhan A; Singh J; Sangwan N; Avti PK
    J Recept Signal Transduct Res; 2024 Feb; 44(1):8-18. PubMed ID: 38529713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can molecular dynamics simulations improve the structural accuracy and virtual screening performance of GPCR models?
    Kapla J; Rodríguez-Espigares I; Ballante F; Selent J; Carlsson J
    PLoS Comput Biol; 2021 May; 17(5):e1008936. PubMed ID: 33983933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in computational studies of GPCR-G protein interactions.
    Wang J; Miao Y
    Adv Protein Chem Struct Biol; 2019; 116():397-419. PubMed ID: 31036298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiscale Molecular Modeling in G Protein-Coupled Receptor (GPCR)-Ligand Studies.
    Nakliang P; Lazim R; Chang H; Choi S
    Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32325877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational Design of Drugs Targeting G-Protein-Coupled Receptors: A Structural Biology Perspective.
    Khorn PA; Luginina AP; Pospelov VA; Dashevsky DE; Khnykin AN; Moiseeva OV; Safronova NA; Belousov AS; Mishin AV; Borshchevsky VI
    Biochemistry (Mosc); 2024 Apr; 89(4):747-764. PubMed ID: 38831510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orphan receptor GPR88 as a potential therapeutic target for CNS disorders - an
    Garisetti V; Dhanabalan AK; Dasararaju G
    J Biomol Struct Dyn; 2024 Jun; 42(9):4745-4758. PubMed ID: 37306437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple open source bioinformatic methodology for initial exploration of GPCR ligands' agonistic/antagonistic properties.
    Panagiotopoulos AA; Papachristofi C; Kalyvianaki K; Malamos P; Theodoropoulos PA; Notas G; Calogeropoulou T; Castanas E; Kampa M
    Pharmacol Res Perspect; 2020 Aug; 8(4):e00600. PubMed ID: 32662237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibiting a promiscuous GPCR: iterative discovery of bitter taste receptor ligands.
    Fierro F; Peri L; Hübner H; Tabor-Schkade A; Waterloo L; Löber S; Pfeiffer T; Weikert D; Dingjan T; Margulis E; Gmeiner P; Niv MY
    Cell Mol Life Sci; 2023 Apr; 80(4):114. PubMed ID: 37012410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deorphanization of G Protein Coupled Receptors: A Historical Perspective.
    Franchini L; Orlandi C
    Mol Pharmacol; 2024 May; 105(6):374-385. PubMed ID: 38622017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flavonoids as G Protein-coupled Receptors Ligands: New Potential Therapeutic Natural Drugs.
    Chda A; Bencheikh R
    Curr Drug Targets; 2023; 24(17):1346-1363. PubMed ID: 38037994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in application of advancing computational approaches in GPCR ligand discovery.
    Zhu S; Wu M; Huang Z; An J
    Exp Biol Med (Maywood); 2021 May; 246(9):1011-1024. PubMed ID: 33641446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring Diverse Signaling Mechanisms of G Protein-Coupled Receptors through Structural Biology.
    Suno R
    J Biochem; 2024 Mar; 175(4):357-365. PubMed ID: 38382646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GOMoDo: A GPCRs online modeling and docking webserver.
    Sandal M; Duy TP; Cona M; Zung H; Carloni P; Musiani F; Giorgetti A
    PLoS One; 2013; 8(9):e74092. PubMed ID: 24058518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial intelligence-enabled virtual screening of ultra-large chemical libraries with deep docking.
    Gentile F; Yaacoub JC; Gleave J; Fernandez M; Ton AT; Ban F; Stern A; Cherkasov A
    Nat Protoc; 2022 Mar; 17(3):672-697. PubMed ID: 35121854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Art and Science of Molecular Docking.
    Paggi JM; Pandit A; Dror RO
    Annu Rev Biochem; 2024 Apr; ():. PubMed ID: 38594926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of genome-edited and endogenously expressed G protein-coupled receptors.
    Soave M; Stoddart LA; White CW; Kilpatrick LE; Goulding J; Briddon SJ; Hill SJ
    FEBS J; 2021 Apr; 288(8):2585-2601. PubMed ID: 33506623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.